|
AN
AUDIT OF ELECTRONIC PRESCRIBING USING THE CLINICAL INFORMATION SYSTEM ON THE
ITU AT RSCH
Corb
S
Brighton & Sussex University Hospitals NHS Trust, Royal Sussex
County Hospital, Brighton, England BN2 5BE
Shani.Corb@bsuh.nhs.uk
Introduction
The national strategic programme, published by the Department of Health, is
concerned with major developments in the deployment and use of Information
Technology (IT) in the NHS. In line with the plan for IT and other Intensive
Therapy Units (ITUs) around the country, the ITU at the Royal Sussex County
Hospital (RSCH) implemented the electronic Clinical Information System (CIS) in
2002 with the prescribing side of the system being fully operational from August
2004. It was noted that during the initial period following the implementation
of full electronic prescribing, certain errors were recurring and potentially
putting patient safety at risk so the aim of this audit was to establish a
baseline level of error so that solutions could be formulated and implemented to
improve practice.
Methodology
Data collection was performed from 30 August 2004 to 30 September 2004;
approximately one month after full electronic prescribing was implemented. The
errors were identified by the pharmacist during the clinical screening of the
electronic prescriptions and recorded by way of a customised data collection
form.
Results
The majority of prescribing errors occurred in the first four days of the
ITU admission. The number of errors as a result of the electronic prescribing
documented during the audit was 67 and the number of general clinical pharmacy
interventions over the same time period was 60. This represents an increase in
the pharmacist’s workload of 112 percent. The most common drugs associated
with errors were salbutamol nebules, ranitidine and paracetamol. The most common
errors were duplication of prescriptions (n=31) by doctors and also nurses,
possibly accidentally, and incorrect frequency (n=12). As the most common error
was duplication, the action taken in 49 percent of cases was to cancel those
duplicated prescriptions (n=33). Other courses of action were for the SHO to
re-prescribe the drug entry (n=15) and the computer’s default for a specific
drug was altered in an attempt to minimise error with that entry. Errors that
were made and could not be undone used "sticky notes" or comments on
the drug tab to justify the action.
Conclusion
The audit fulfilled the aim of establishing a baseline level of error with
electronic prescribing on the CIS. The types of errors have been identified and
steps can now be taken to minimise them. The two main areas have been targeted
for improvement as result of this audit are training and programming. The issues
that require alterations to programming could be reviewed and implemented where
possible to facilitate ease of use. Training needs of staff are being addressed
and it is planned that the pharmacist in conjunction with the system programmers
will design a competency-based workbook in time for the new team of SHOs that
are due to rotate to the ITU in February 2005. The workbook will include
examples of errors from this audit as a learning tool. There should be a
re-audit at a suitable time interval to ascertain if the measures taken as a
result of this audit have been effective.
Presented at the HSRPP Conference 2005, Reading
|